SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A slight decline in the revenue of Rs. 50962.10 millions was seen for the September 2023 quarter as against Rs. 52852.90 millions during year-ago period.Net profit declined -26.74% to Rs. 8886.30 millions from Rs. 12130.10 millions.The Operating Profit of the company witnessed a decrease to 14928.60 millions from 17048.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 50962.10 52852.90 -3.58 95622.80 102181.70 -6.42 208121.40 155859.80 33.53
Other Income 1159.30 417.10 177.94 2794.70 2179.20 28.24 3292.90 11968.80 -72.49
PBIDT 14928.60 17048.80 -12.44 26051.60 32035.30 -18.68 67518.90 38654.40 74.67
Interest 1936.30 927.70 108.72 3515.70 1798.40 95.49 4721.80 3881.00 21.66
PBDT 12992.30 16121.10 -19.41 21043.80 30236.90 -30.40 33419.20 16568.10 101.71
Depreciation 3927.10 3839.50 2.28 8079.80 7584.50 6.53 16008.70 13499.50 18.59
PBT 9065.20 12281.60 -26.19 12964.00 22652.40 -42.77 17410.50 3068.60 467.38
TAX 178.90 151.50 18.09 271.30 404.30 -32.90 503.30 4068.50 -87.63
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 8886.30 12130.10 -26.74 12692.70 22248.10 -42.95 16907.20 -999.90 -1790.89
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 29.29 32.26 -9.19 27.24 31.35 -13.10 32.44 24.80 30.81

Sun Pharma Inds. Share Price

1675.20 -17.95 (-1.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×